Atlas Trials

Treating Locally Advanced Head and Neck Malignant Tumor With Anlotinib and Chemoradiotherapy

Clinical trial NCT04507035 · UNKNOWN

Trial details

NCT number
NCT04507035
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Head and Neck Cancer
Start date
2020-09-01
Primary completion
2022-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.